Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Pokaż inne wersje (1)

Introduction: Neuromyelitis optica (NMO) is a severe demyelinating disease that preferentially involves spinal cord and optic nerve. It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensiti...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Downer, J, Leite, M, Carter, R, Palace, J, Küker, W, Quaghebeur, G
Format:	Journal article
Język:	English
Wydane:	2012

Podobne zapisy

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
od: Downer, J, i wsp.
Wydane: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
od: Jarius, S, i wsp.
Wydane: (2007)

Neuromyelitis Optica (NMO) — Study Review
od: Justyna Chojdak-Łukasiewicz
Wydane: (2021-06-01)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
od: Murchison, A, i wsp.
Wydane: (2013)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
od: Littleton, E, i wsp.
Wydane: (2006)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
od: Sudulagunta, Sreenivasa Rao, i wsp.
Wydane: (2015-11-01)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
od: Marco A. Lana-Peixoto, i wsp.
Wydane: (2011-08-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
od: Sung-Min Kim, i wsp.
Wydane: (2017-07-01)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
od: Matthews, L, i wsp.
Wydane: (2012)

Magnetic resonance imaging in neuromyelitis optica.
od: Tackley, G, i wsp.
Wydane: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
od: Matthews, L, i wsp.
Wydane: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
od: Matthews, L, i wsp.
Wydane: (2013)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
od: Matthews, L, i wsp.
Wydane: (2012)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
od: Kim, W, i wsp.
Wydane: (2012)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
od: Jacob, A, i wsp.
Wydane: (2009)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
od: Collongues, N, i wsp.
Wydane: (2013)

Racial differences in neuromyelitis optica spectrum disorder
od: Kim, S, i wsp.
Wydane: (2018)

Delayed diagnosis of the neuromyelitis optica spectrum disorder
od: S. A. Dzhukkaeva, i wsp.
Wydane: (2023-08-01)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
od: Kitley, J, i wsp.
Wydane: (2014)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
od: Nour, M, i wsp.
Wydane: (2014)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
od: Jarius, S, i wsp.
Wydane: (2007)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
od: Jarius, S, i wsp.
Wydane: (2007)

Neuromyelitis optica spectrum disorder
od: Simon Broadley, i wsp.
Wydane: (2017-09-01)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
od: George, J, i wsp.
Wydane: (2012)

The evolving clinical spectrum of neuromyelitis optica
od: Viegas, S, i wsp.
Wydane: (2008)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
od: Mohammad Hossein Harirchian, i wsp.
Wydane: (2015-02-01)

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
od: Matthews, L, i wsp.
Wydane: (2013)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
od: Akman-Demir, G, i wsp.
Wydane: (2008)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
od: Tarso Adoni, i wsp.
Wydane: (2008-06-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
od: Viegas, S, i wsp.
Wydane: (2009)

Use of mitoxantrone in neuromyelitis optica.
od: Kitley, J, i wsp.
Wydane: (2011)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
od: Kitley, J, i wsp.
Wydane: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
od: Kitley, J, i wsp.
Wydane: (2013)

Pediatric neuromyelitis optica spectrum disorder
od: Aman Mehta
Wydane: (2024-01-01)

Hypersomnia in Neuromyelitis Optica Spectrum Disorders
od: Hasan Can Güdek, i wsp.
Wydane: (2024-06-01)

Neuromyelitis optica spectrum disorders in children
od: N. F. Akhmetgaleeva, i wsp.
Wydane: (2024-08-01)

Relapsing neuromyelitis optica spectrum disorder
od: M Lakshmi Lavanya, i wsp.
Wydane: (2021-01-01)

Neuromyelitis optica spectrum disorders: An update
od: Lekha Pandit
Wydane: (2015-01-01)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
od: Kitley, J, i wsp.
Wydane: (2013)

Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
od: Francis, A, i wsp.
Wydane: (2024)